Relationship between adolescent amenorrhea and climacteric osteoporosis

Maturitas

Volumn 56, Issue 4, 2007, Pages 368-374

  Csermely, Tamás ^a   Halvax, László ^a   Vizer, Miklós ^a   Drozgyik, István ^a   Tamás, Péter ^a   Göcze, Péter ^a   Szabó, István ^a   Jeges, Sára ^a   Szilágyi, András ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Adolescence; Amenorrhea; Menopause; Osteoporosis

Indexed keywords

ADOLESCENT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; OSTEOPOROSIS; OUTPATIENT DEPARTMENT; QUESTIONNAIRE;

ADOLESCENT; AMENORRHEA; BONE DENSITY; CHILD; FEMALE; HUMANS; HUNGARY; LUMBAR VERTEBRAE; MENARCHE; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 33947289600     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.10.003     Document Type: Article

References (39)

1. International Osteoporosis Foundation. The facts about osteoporosis and its impact. International Osteoporosis Foundation Website. Available at: http://www.osteofound.org.press_centre/fact_sheet.html [Accessed July 26, 2005].
2. Lane N.E. Epidemiology, etiology and diagnosis of osteoporosis. Am J Obstet Gynecol 194 Suppl. 2 (2006) S3-S11
3. National Osteoporosis Foundation. America's bone health: the state of osteoporosis and low bone mass in our nation (2002), National Osteoporosis Foundation, Washington, DC
4. Gordon C.M. Bone density issues in the adolescent gynecology patient. J Pediatr Adolesc Gynecol 13 (2000) 157-161
5. National Institute of Health. NIH consensus statement: osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 17 (2000) 1-45
6. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy. JAMA 2001;285:785-95.
7. Hergenroeder A.C. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 126 (1995) 683-689
8. Schettler A.E., and Gustafson E.M. Osteoporosis prevention starts in adolescence. J Am Acad Nurse Pract 16 (2004) 274-282
9. Mora S., and Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin North Am 32 (2003) 39-63
10. Rubin L.A., Hawker G.A., Peltekova V.D., Fielding L.J., Ridout R., and Cole D.E. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 14 (1999) 633-643
11. Eastel R. Pathogenesis of postmenopausal osteoporosis. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. (2003), American Society for Bone and Mineral Research, Washington, DC 314-316
12. Legroux-Gerot I., Vignau J., Collier F., and Cortet B. Bone loss associated with anorexia nervosa. Joint Bone Spine 72 (2005) 489-495
13. Bondy C.A. New issues in the diagnosis and management of Turner syndrome. Rev Endocr Metab Disord 6 (2005) 269-280
14. Birch K. Female athlete triad. BMJ 330 (2005) 244-246
15. Koutedakis Y., and Jamurtas A. The dancer as a performing athlete: physiological considerations. Sports Med 34 (2004) 651-661
16. Csermely T., Halvax L., Schmidt E., Zámbó K., Vadon G., and Szabó I. Occurrence of osteopenia among adolescent girls with oligo-amenorrhea. Gynecol Endocrinol 16 (2002) 99-105
17. Dennison E., Cole Z., and Cooper C. Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol 17 (2005) 456-461
18. Creatsas G., Arefetz N., Adamopoulos P.N., Konstantellou E., and Aravantinos E. Transdermal estradiol plus oral medroxyprogesterone acetate replacement therapy in primary amenorrheic adolescents. Clinical, hormonal and metabolic aspects. Maturitas 18 (1994) 105-114
19. Volpe A., Malmusi S., Zanni A.L., Landi S., and Cagnacci A. Oral contraceptives and bone metabolism. Eur J Contracept Reprod Health Care 2 (1997) 225-228
20. Lochmüller E.M., Müller R., Kuhn V., Lill C.A., and Eckstein F. Can novel clinical densitometer techniques replace or improve DEXA in predicting bone strength in osteoporosis at the hip and other skeletal sites?. J Bone Miner Res 18 (2003) 906-912
21. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994;843:1-129.
22. Winzberger T.M., Shaw K., Fryer J., and Jones G. Calcium supplementation for improving bone mineral density in children. Cohrane Database Syst Rev April 19 2 (2006) CD005119
23. Lips P. Vit D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
24. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis (2003), National Osteoporosis Foundation, Washington, DC pp. 1-37
25. Picard D., Imbach A., Couturier M., Lepage R., and Ste Marie L.-G. Longitudinal study of bone density and its determinants in women in peri- or early menopause. Calcif Tissue Int 67 (2000) 356-360
26. Ravn P., Cizza G., Bjarnason N.H., et al. Low body mass is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) Study Group. J Bone Miner Res 14 (1999) 1622-1627
27. Lasco A., Morabito N., Gaudio A., Buemi M., Wasniewska M., and Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int 12 (2001) 570-575
28. Heger S., Sippell W.G., and Partsch C.J. Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience. Endocr Dev 8 (2005) 94-125
29. Fedele L., and Berlanda N. Emerging drugs for endometriosis. Expert Opin Emerg Drugs 9 (2004) 167-177 Informa Healthcare ISSN 1472-8214
30. Gordon C.M., and Nelson L.M. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol 15 (2003) 377-384
31. Miller K.K., and Klibanski A. Amenorrheic bone loss. J Clin Endocrinol Metab 84 (1999) 1775-1783
32. Mirza F.S., and Prestwood K.M. Bone health and aging: implications for menopause. Endocrinol Metab Clin North Am 33 (2004) 741-759
33. Kaplan F.S. Prevention and management of osteoporosis. In: Erdélyi-Brown M. (Ed). Clinical symposia vol. 47 (1995), Ciba-Geigy Corporation, New Jersey pp. 1-32
34. Manolagas S.C., Kousteni S., and Jilka R.L. Sex steroids and bone. Recent Prog Horm Res 57 (2002) 385-409
35. Tudor-Locke C., and McColl R.S. Factors related to variation in premenopausal bone mineral status: a health promotion approach. Osteoporos Int 11 (2000) 1-24
36. Cooper G.S., and Sandler D.P. Long effects of reproductive-age menstrual cycle patterns on peri- and postmenopausal fracture risk. Am J Epidemiol 145 (1997) 804-809
37. Puntila E., Kroger H., Lakka T., Honkanen R., and Tuppurainen M. Physical activity in adolescence and bone density in peri- and postmenopausal women: a population-based study. Bone 21 (1997) 363-367
38. Delaney M.F. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 194 Suppl. 2 (2006) S12-S23
39. McGee C. Secondary amenorrhea leading to osteoporosis: incidence and prevention. Nurse Pract 22 (1997) 41-45